A Randomised Phase III Clinical Trial Comparing Surgery Alone with Concurrent Preoperative Chemotherapy and Radiation Followed by Surgery For Localised Resectable Carcinoma of the Oesophagus
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Collaborating Groups
Australasian Gastro-Intestinal Cancer Trials Group (AGITG)
Related Post
20 May, 2026
TROG trials in the spotlight at ESTRO26 international conference
LATEST NEWS: 20 MAY A number of TROG trials
18 May, 2026
FASTRACK II trial finds emerging radiotherapy technique effectively controls kidney cancer
LATEST NEWS: 18 MAY 2026 A new non-invasive form